insights_auto
Why is EMCURE up 2.09%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,387.70
arrow_upward
+2.09%(+48.90) 1D
Nov 17, 11:11:03 AM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹2,338.80
High
₹2,397.50
Low
₹2,335.20
Mkt. cap
452.97B
Avg. vol.
229.17K
Volume
71.33K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
50.12
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
Open
₹2,338.80
High
₹2,397.50
Low
₹2,335.20
Mkt. cap
452.97B
Avg. vol.
229.17K
Volume
71.33K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
50.12
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
News stories
From web sources and news partners
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
9 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
14 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
6 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com